| Financial Year |
March 31 2023 |
| Monetary Funds |
140,901,061.65 |
| Held-for-trading Financial Assets |
400,258,800.00 |
| Notes Receivable |
47,285,858.08 |
| Accounts Receivable |
141,383,630.55 |
| Advances to Suppliers |
3,320,251.53 |
| Other Receivables |
3,584,944.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
142,868,116.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
163,664,419.55 |
| Total Current Assets |
1,056,886,278.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
161,434,717.94 |
| Under-construction Projects |
1,280,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,148,579.02 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,069,303.16 |
| Deferred Income Tax Assets |
3,218,763.73 |
| Other Non-Current Assets |
26,347,725.30 |
| Sub-Total of Non-Current Assets |
225,116,757.74 |
| Total Assets |
1,282,003,036.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,778,527.19 |
| Accounts Payable |
80,305,689.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,230,686.62 |
| Taxes Payable |
4,869,595.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,628,854.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,263,794.39 |
| Other Current Liabilities |
2,028,873.53 |
| Sub-Total of Current Liabilities |
129,672,310.12 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,965,035.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,401,843.39 |
| Total Liabilities |
144,074,153.51 |
| Paid-In Capital(Or Share Stock) |
96,000,300.00 |
| Capital Surplus |
831,173,748.40 |
| Surplus Reserve |
39,015,130.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
171,739,703.61 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,137,928,882.67 |
| Owner's Equity（Stockholder's Equity） |
1,137,928,882.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,282,003,036.18 |
